Recent Advances in Research into Vaccine Technologies
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 2644
Special Issue Editors
Interests: lipoplexes; liposomes; biophysics; bionanosystems; contact lenses; gene therapy; drug-delivery; vaccines
2. Institute of Science and Innovation for Sustainability (IB-S), Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal
Interests: controlled delivery system; liposomes; antioxidants; anti-inflammatory; sustainable production
Special Issues, Collections and Topics in MDPI journals
Interests: invasive fungal infections; fungal molecular identification; fungal pathogenesis; host-fungus interaction
Special Issues, Collections and Topics in MDPI journals
Interests: nanocarriers; nanotherapeutics; membrane model systems; ADMET profiling; biophysical techniques
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pathogenic infections are spreading rapidly in an increasingly globalized world due to migratory movements and cross-national contact. With globalization, certain restricted or geographically localized infections are also becoming global. Furthermore, the current pandemic has demonstrated the importance of an annual profilaxy against recurrent infections. This also creates a necessity to develop multipurpose vaccines, targeting different infectious agents. Concerns about weak immunogenicity, intrinsic in vivo instability and toxicity should be also a focus in vaccine development. These global challenges create an opportunity for the translation to the clinics of nanotechnology-based carriers for antigens and nucleic acids.
We welcome contributions including original research articles as well as field reviews relating to this research topic. The goal of the Special Issue is to provide an overview of the current state of the art, as well as to highlight recent discoveries and future prospects for nanotechnology-based vaccines.
Prof. Dr. Maria Elisabete C. D. Real Oliveira
Prof. Dr. Andreia Gomes
Dr. Paula Sampaio
Dr. Marlene Lucio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanovaccines
- nanobiotechnology
- immunology
- toxicology, antigen delivery
- nucleic acid delivery
- pandemic infections
